Clinical trial

Safety and Efficacy Study of Fluticasone Furoate/Vilanterol (FF/VI) Fixed Dose Combination (FDC) Compared to FF Alone in Subjects With Asthma

NCT03248128

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention FF/VI via ELLIPTA DPI Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention FF via ELLIPTA DPI Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Safety and Efficacy Study of Fluticasone Furoate/Vilanterol (FF/VI) Fixed Dose Combination (FDC) Compared to FF Alone in Subjects With Asthma

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-10-20

PhasePHASE3

Conditions

Asthmaverified · MONDO: asthma

Interventions

FF/VI via ELLIPTA DPIDRUG

FF via ELLIPTA DPIDRUG

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

Saint PetersburgRussia10 MoscowRussia6 TokyoJapan6 MiamiFlorida, United States5 San AntonioTexas, United States3 Buenos AiresArgentina3 BucharestRomania3 BarcelonaSpain2 OrlandoFlorida, United States2 DenverColorado, United States2 BudapestHungary2 SofiaBulgaria2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03248128 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.